United States: Jury Returns Defense Verdict In Third Post-Pandemic Ovarian Cancer Talc Trial 11 October 2021 by Magda Patitsas and Corey M. Schaecher Husch Blackwell LLP To print this article, all you need is to be registered or login on Mondaq.com. On September 27, 2021, after 18 days of trial and a mere hour of deliberations, a City of St. Louis, Missouri jury rendered a defense verdict in favor of Johnson & Johnson ("J&J") on claims of three women diagnosed with ovarian cancer. Forrest v.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Corey
Contact Corey, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack